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Abstract
Two simple and sensitive spectrophotometric methods are described for the determination of ethionamide (ETM) in pure drug and
tablets. The first method is based on the reduction of Folin–Ciocalteu (F–C) reagent by ETM in sodium carbonate medium to form
a blue coloured complex, which was measured at 760 nm (Molybdenum–tungsten blue method). In the second method (Prussian
blue method), iron(III) was reduced to iron(II) by ETM in HCl medium, in which iron(II) was complexed with ferricyanide, and the
resulting Prussian blue was also measured at 760 nm. The absorbance measured in each case was related to the ETM concentration.
The experimental conditions were carefully studied and optimised. Beer’s law was obeyed in concentration ranges of 1–40 g/ml
and 0.2–4.0 g/ml with the Molybdenum-tungsten blue method and the Prussian blue method, respectively, with corresponding
molar absorptivity values of 5.72 ×  103 and 3.18 ×  104 l/(mol·cm). The limits of detection (LOD) and quantification (LOQ) were
0.09 and 0.27 g/ml for the Molybdenum-tungsten blue method and 0.01 and 0.04 g/ml for the Prussian blue method. Within-day
and between-day relative standard deviations (%RSD) at three different concentration levels were <3%, and the respective relative
errors (%RE) were ≤2%, implying good accuracy and precision of the methods. The proposed methods were successfully applied
to the determination of ETM in bulk powder and tablets, and the results demonstrated that the methods were as accurate and precise
as the official method.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1.  Introduction
Ethionamide (ETM), chemically known as 2-
ethylthioisonicotinamide, is a second-line, orally admin-
istered drug for the treatment of multi-drug resistant
tuberculosis (MDR-TB) [1]. ETM is efficacious, rela-
tively non-toxic, cheap, readily available, and has been
in use since the 1960s [2]. The drug is officially in
the United States Pharmacopoeia [3], which describes
a UV-spectrophotometric method for its assay. In the
N.A.S. Qarah et al. / Journal of Taibah University for Science 11 (2017) 718–728 719
British Pharmacopoeia (BP) [4], the drug is identified
by potentiometric titration with HClO4 in anhydrous
acetic acid medium. Analytical methods reported for
the determination of ETM in bodily fluids are gen-
erally based on chromatographic techniques, such as
high performance liquid chromatography [5–10] and
liquid-chromatography-tandem mass spectrometry [11],
because of the high sensitivity required in such matrices.
Published methods for the determination of ETM in
bulk drug and tablets are based on some techniques
such as titrimetry (with visual [12] or potentiometric
[13,14] end point detection), fluorimetry [15] and vis-
ible spectrophotometry employing various chromogenic
agents such as dichlone [16,17], iron(III) [18], iron(III)-
p-phenylenediamine [19], sodium nitroprusside [20,21],
pyridylazo-resorcinol-vanadium [22], osmic acid [23],
alizarin violet 3B and alizarin brilliant violet R [24],
N-bromosuccinimide (NBS)-celestine blue (CB) [25],
permanganate [26] and iodine [27].
The indirect method [25] based on the redox reac-
tion requires the concentration of both the oxidant (NBS)
and the dye (CB) to be accurately known. On the other
hand, the other two methods [26,27] are based on the
measurement of an absorbance change as a function
time (kinetic), thus requiring careful control of all the
experimental variables involved. The remaining spec-
trophotometric methods involve drastic experimental
conditions, less sensitive and/or are applicable over nar-
row linear dynamic concentration ranges.
This paper describes two simple, sensitive and val-
idated spectrophotometric methods based on a redox
reaction employing reagents whose concentrations do
not need to be accurately known. The methods are based
on the reduction of either Folin–Ciocalteu (F–C) reagent
by ETM in alkaline medium to molybdenum-tungsten
blue (Molybdenum-tungsten blue method) or iron(III)
to (II) in acid medium, which is subsequently com-
plexed with ferricyanide to yield Prussian blue (Prussian
blue method). The coloured product is measured at
760 nm in both methods. The reaction conditions were
thoroughly studied, and under optimum conditions, the
Prussian blue method provides a highly sensitive proce-
dure for the determination of ETM in commercial drug
products.
2.  Experimental
2.1.  Apparatus
A Systronics model 166 digital spectrophotometer
(Systronics, Ahmedabad, Gujarat, India) with matched
1-cm quartz cells was used for absorbance measure-
ments.
2.2.  Materials  and  methods
A pure ethionamide (ETM) sample, certified to be
99.86% pure, was procured from Panacea Biotic Ltd.,
New Delhi, India, as a gift and was used as received.
ETM-containing tablets, i.e., Ethide (Lupin Ltd.,
Mumbai, India), Ethiokox (Radicura Private Ltd., New
Delhi, India) and Myobid (Panacea Biotic, New Delhi,
India), each contained 250 mg of active ingredient and
were purchased from local commercial sources.
A Folin–Ciocalteu (F–C) reagent solution (1:1) was
prepared by mixing 50 ml of the F–C reagent (Merck,
Mumbai, India) with 50 ml of water in a 100 ml cali-
brated flask.
An iron(III) solution, i.e., a solution of 1% (w/v)
FeCl3·6H2O, was prepared by dissolving 1 g of the
chemical (S.D. Fine Chem. Ltd., Mumbai, India) in
100 ml of 0.1 M HCl (Merck, Mumbai, India).
A potassium ferricyanide solution, i.e., a solution of
0.5% (w/v) ferricyanide, was prepared by dissolving
0.5 g of the chemical (Glaxo Laboratory, Mumbai, India)
in 100 ml of water.
A sodium carbonate solution, i.e., a solution of 20%
(w/v) Na2CO3, was prepared by dissolving 20 g of the
chemical (S.D. Fine Chem. Ltd., Mumbai, India) in
100 ml of water.
A standard stock ETM solution (100 g/ml) was
prepared by dissolving the calculated quantity of pure
drug in 0.1 M HCl for use in the Molybdenum-tungsten
method. The stock solution was diluted to 20 g/ml with
0.1 M HCl for use in the Prussian blue method.
2.3.  General  procedures
2.3.1.  Preparation  of  calibration  curves
2.3.1.1.  Molybdenum-tungsten  blue  method  (MTB
method). Different aliquots (0.1, 0.2, 0.5, 1.0, 2.0, 3.0,
4.0 ml) of a 100 g/ml standard ETM solution were
accurately transferred into a series of 10 ml calibrated
flasks. Subsequently, 1.5 ml of the Na2CO3 and F–C
reagent solutions were sequentially added to each flask,
and the volume was increased with water to the required
mark; the solution was then mixed well. After 10 min,
the absorbance of each solution was measured at 760 nm
versus  the reagent blank.
2.3.1.2.  Prussian  blue  method  (PB  method).  Aliquots
of the 20 g/ml ETM solution (0.1, 0.2, 0.5, 1.0, 1.5,
2.0 ml) were placed in a series of 10 ml calibrated flasks.
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Two millilitres of both iron(III) and ferricyanide solu-
tions were added to each flask, followed by the addition
of 2.0 ml of concentrated HCl. The volume was brought
to 10 ml with 0.1 M HCl and mixed well. The flasks were
incubated for 30 min, and the absorbance was measured
at 760 nm versus  the reagent blank.
In each case, the standard graph was prepared by plot-
ting the measured absorbance versus  the concentration
of ETM, and the concentration of the unknown was com-
puted using the regression equation derived from Beer’s
law data.
2.3.2.  Procedure  for  tablets
Twenty tablets were accurately weighed and ground
into a fine powder. A portion of the powder, equivalent to
20 mg of ETM, was accurately weighed and transferred
into a 100 ml calibrated flask. Sixty millilitres of 0.1 M
HCl were added, and the solution was shaken for 20 min.
The volume was diluted to the mark with 0.1 M HCl
and mixed well, and the insoluble residue was removed
by filtration with Whatman 42 filter paper. The filtrate
(200 g/ml of ETM) was diluted to 100 and 20 g/ml
levels for the MTB method assay and the PB method
assay, respectively. A one millilitre standard solution in
five replicates were used for analysis in both the methods.
2.3.3. Procedures  for  method  validation
All assay validation procedures were carried out
according to current ICH guidelines [28], which include
linearity, limits of detection (LOD) and quantification
(LOQ), intra-day and inter-day precision and accuracy,
robustness and ruggedness, selectivity and recovery.
2.3.3.1. Linearity,  LOD  and  LOQ.  Linearity was
assessed by analysing a set of seven/six calibration stan-
dards. Calibration curves were prepared as described
above in the “Preparation of calibration curves” Sec-
tion 2.3.1. The linearity of the methods was determined
by plotting the absorbance (Y) against the theoretical
concentration (X) of ETM. Calibration measurements
were subjected to least square regression analysis to
obtain information related to the slope, the Y-intercept,
the correlation coefficient (r) and the back-calculated
concentrations. The coefficient of correlation should be
0.9800 or greater. The LOD and LOQ values were cal-
culated using the following formulas [29]:
LOD = 3.3S
m
and LOQ = 10S
m
where S is the standard deviation of replicate (n  = 7)
blank absorbances, and m  is the slope of the calibration
curve.
2.3.3.2.  Precision  and  accuracy.  To evaluate the pre-
cision and accuracy of the methods, a standard drug
solution at three concentration levels was subjected to
same day (intra-day) analysis in seven replicates, as
well as on five consecutive days (inter-day analysis)
by preparing all solutions a fresh each day. The mean
and standard deviations (SD) were obtained by back-
calculated drug concentration at each level. The accuracy
and precision were evaluated in terms of relative error
(RE) and relative standard deviation (RSD), respectively.
2.3.3.3. Robustness  and  ruggedness.  Robustness was
examined by evaluating the influence of small varia-
tions in method variables, including the amounts of
analytical reagents and the reaction time, on the perfor-
mance of the proposed methods. In these experiments,
one parameter was changed while the others were kept
unchanged, and the %RSD was calculated each time.
Ruggedness was also tested by applying the proposed
methods to determine ETM using the same experimental
conditions by three analysts using the same instrument
(inter-personnel) and also by a single analyst using three
different instruments (inter-instrument). These assays
were performed at three concentration drug levels.
2.3.3.4. Selectivity.  The selectivity of the methods was
examined using placebo blank and synthetic mix-
ture analyses. A placebo blank, whose composition is
20 mg talc, 30 mg starch, 20 mg sucrose, 20 mg lactose,
10 mg gelatin, 20 mg sodium alginate, 30 mg magnesium
stearate, and 20 mg methyl cellulose, was prepared by
homogeneous mixing in a mortar. Ten milligrams of the
placebo was placed in a 50 ml calibration flask, and its
extract was prepared as described in Section 2.3.2. Two
millilitres of the extract were analysed according to gen-
eral procedures. Twenty milligrams of pure ETM was
added to 10 mg of the previously prepared placebo blank,
and the solution was thoroughly mixed. The mixture was
quantitatively transferred to a 100 ml calibrated flask,
and the steps described in Section 2.3.2 were followed.
3.  Results  and  discussion
3.1.  Absorption  spectra
The quantitative determination of many phenolic and
amino compounds of pharmaceutical importance using
F–C reagent is well-known [30–37] and involves the
reduction of the yellow molybdotungsto phosphoric acid
heteropolyanion reagent by the phenols or amines and
the measurement of the absorbance of the resultant
molybdotungstrate blue [38,39]. In the present MTB
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Fig. 1. Absorption spectra of the MTB method: (A) Reaction product
of ETM (15 g/ml) with F–C reagent in Na2CO3 solution; (B) the
blank.
method, F–C reagent was reduced by ETM in sodium
carbonate medium to produce an intense, blue-coloured
product [38,39] that peaks at 760 nm (Fig. 1).
In the PB method, due to the reducing nature
of ETM, iron(III) was reduced to iron(II) in acid
medium. Subsequently, the iron(II) formed in  situ
reacted with ferricyanide to form soluble Prussian
blue, [KFeIII[FeII(CN)6]] similar to previous reports
[40–45]. Prussian blue also absorbs maximally at 760 nm
(Fig. 2). The possible reaction pathways are presented in
Fig. 3.
3.2.  Method  development
In the MTB method, the experimental variables, i.e.,
the contact time, the amount of F–C reagent and sodium
carbonate, and addition order of the reactants, were
Fig. 2. Absorption spectra of PB method: (A) Reaction product of
ETM (2 g/ml) with iron(III) and ferricyanide in HCl medium; (B)
the corresponding blank.
carefully studied and optimised. Maximum absorbance
was reached 10 min after mixing the reactants, and the
colour remained stable for as long as 24 h. Equal vol-
umes (1.5 ml each) of the F–C reagent (1:1) and sodium
carbonate (20%) solutions were found to be optimal at a
total volume of 10 ml, as shown in Fig. 4a and b. With
respect to the addition order of reactants, the order indi-
cated in the recommended procedure yielded coloured
species with higher sensitivity and stability.
Blue colour formation in the PB method was found
to be somewhat slow, and maximum colour intensity
was achieved after 30 min, remaining stable for an addi-
tion 60 min under optimum conditions. Two millilitres of
both iron(III) and ferricyanide solutions, as well as con-
centrated HCl, added sequentially, resulted in maximal
sample colour intensity and minimal blank absorbance
as indicated in Fig. 5a–c.
Fig. 3. Possible reaction pathways yielding coloured species.
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Fig. 4. (a) Effect of the F–C reagent concentration (ETM, 15 g/ml). (b) Effect of 20% Na2CO3 (ETM, 15 g/ml).
4.  Method  validation
4.1.  Linearity  and  sensitivity
A linear correlation was found between the
absorbance at λmax and the ETM concentration in the
ranges given in Table 1. The graphs (Fig. 6a and b)
showed a negligible intercept, as described by the regres-
sion equation:
Y  =  b  +  mX
where Y  is the measured absorbance, X is the con-
centration in g/ml, and m  and b  are the slope and
intercept, respectively. Regression analysis of Beer’s law
data using the method of least squares was used to cal-
culate the slope (m), the intercept (b) and the correlation
coefficient (r) of each system. These values are presented
in Table 1. Beer’s law ranges, molar absorptivity values
and Sandell’s sensitivity values are shown in Table 1.
The calculated values of limits of detection (LOD) and
quantification (LOQ) are also included in Table 1, high-
lighting the high sensitivity of these methods.
N.A.S. Qarah et al. / Journal of Taibah University for Science 11 (2017) 718–728 723
Fig. 5. (a) Effect of the iron(III) concentration (ETM, 2.0 g/ml). (b)
Effect of the potassium ferricyanide concentration (ETM, 2.0 g/ml).
(c) Effect of the HCl concentration (ETM, 2.0 g/ml).
4.2.  Accuracy  and  precision
The results of intra-day and inter-day precision and
accuracy for the proposed methods are presented in
Table 2. The precision is expressed as the %RSD for the
intra-day (reproducibility) and the inter-day (intermedi-
ate precision) assays. The precision for the intra-day and
the inter-day assays were 1.6% and 2.5%, respectively.
Table 1
Sensitivity and regression parameters.
Parameter MTB method PB method
λmax, nm 760 760
Colour stability 24 h 60 min
Linear range, g/ml 1–40 0.2–4.0
Molar absorptivity (ε),
L/(mol·cm)
5.72 × 103 3.18 × 104
Sandell sensitivitya, g/cm2 0.0291 0.0053
Limit of detection (LOD), g/ml 0.09 0.01
Limit of quantification (LOQ),
g/ml
0.27 0.04
Regression equation, Yb
Intercept (b) 0.0468 0.0235
Slope (m) 0.0238 0.1625
Standard deviation of b (Sb) 9.98 × 10−2 9.88 × 10−2
Standard deviation of m (Sm) 2.7 × 10−3 3.3 × 10−2
Regression coefficient (r) 0.9986 0.9992
a Limit of determination as the weight in g/ml of solution, which
corresponds to an absorbance of A = 0.001 measured in a cuvette of
cross-sectional area 1 cm2 and l = 1 cm.
b Y = b + mX, where Y is the absorbance, X concentration in g/ml,
b intercept and m slope.
Fig. 6. (a) Calibration curve for the Molybdenum-tungsten blue
method. (b) Calibration curve for the Prussian blue method.
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Table 2
Evaluation of intra-day and inter-day accuracy and precision.
Method ETM taken, (g/ml) Intra-day accuracy and precision (n = 7) Inter-day accuracy and precision (n = 5)
ETM founda (g/ml) RSDb % REc % ETM Found, (g/ml) RSDb % REc %
MTB 10.0 9.88 0.88 1.20 9.85 1.94 1.50
20.0 19.84 1.27 0.80 19.69 2.32 1.55
30.0 30.48 0.96 1.60 29.44 1.89 1.87
PB 1.0 0.98 1.29 2.00 1.00 1.87 2.00
2.0 1.97 1.36 1.50 1.97 1.47 1.50
3.0 3.04 1.55 1.33 2.95 2.49 1.67
a Mean value of seven determinations.
b Relative standard deviation (%).
c Relative error (%).
The accuracy, expressed as the percentage deviation
between nominal and measured concentrations, was in
the range of 0.8–2.0% for the intra-day and 1.5–2.0% for
inter-day assays.
4.3.  Robustness  and  ruggedness
The results of this study, expressed as the interme-
diate precision (%RSD), are given in Table 3. Small
alterations in method variables did not significantly
affect the results, as shown by low values of %RSD
(<3%). The results for person-to-person and instrument-
to-instrument variations were also reproducible, with
%RSD values of approximately 2%.
4.4.  Selectivity
Replicate analyses of the placebo blank showed
absorbance almost equal to that of reagent blank. When
the synthetic mixture was subjected to analyses at three
concentration levels by the proposed methods, the per-
cent recoveries of pure drug ranged from 98.56 ±  0.88 to
102.6 ±  1.17, indicating non-interference from the inac-
tive ingredients.
4.5.  Application  to  tablets
Three brands of 250 mg strength tablets were ana-
lysed by the proposed methods, and the results are
presented in Table 4. The same tablets were also ana-
lysed by the reference method [4] for comparison. The
reference method involved the potentiometric titration
of acetous solution of tablet with acetous HClO4. The
results revealed that there is close agreement between the
results obtained by the proposed methods and those of
the reference method. Indeed, the results are close to the
label claim. When the results were statistically evaluated
by applying Student’s t-test for accuracy and variance
ratio F-test for precision, the calculated t- and F-values
did not exceed the tabulated values at the 95% confidence
level and for four degrees of freedom. This suggested that
Table 3
Method robustness and ruggedness expressed as intermediate precision (% RSD).
Method ETM taken,
(g/ml)
Robustness (%RSD) Ruggedness (%RSD)
Parameters altered Inter-analysts
(n = 3)
Inter-cuvettes
(n = 3)Contact
timea
Volume of F–C
reagent/iron(III)b
Volume of
Na2CO3/ferricynide
MTB 10 0.76 0.67 0.86 1.23 1.88
20 0.88 0.88 1.12 1.75 1.65
30 1.34 1.58 1.00 0.96 2.07
PB 1 1.68 1.85 1.85 1.22 2.31
2 2.16 1.17 1.46 0.87 1.63
3 2.58 1.74 1.78 1.38 1.77
a Contact time used: 8, 10 and 12 min in MTB method, 28, 30 and 32 min in PB method.
b Volume of F–C reagent/Na2CO3 were: 1.3, 1.5 and 1.7 ml in MTB method; volume of iron(III) and ferricyanide were: 1.8, 2.0 and 2.2 ml in PB
method.
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Table 4
Results of analysis of tablets by the proposed methods and statistical comparison of the results with the official method.
Tablet brand name Nominal amount Founda (% of nominal amount ± SD)
Official method Proposed methods
MTB method PB method
Ethide 250 98.64 ± 1.05
99.72 ± 0.86 97.83 ± 1.12
t = 1.78 t = 1.73
F = 1.49 F = 1.14
Ethiokox 250 100.12 ± 0.65
101.28 ± 1.32 101.34 ± 1.45
t = 1.76 t = 1.72
F = 4.12 F = 4.98
Myobid 250 98.59 ± 1.67
97.96 ± 1.23 100.4 ± 0.93
t = 0.68 t = 2.12
F = 1.84 F = 3.22
a Mean value of five determinations.
(Tabulated t-value at the 95% confidence level and for four degrees of freedom is 2.78).
(Tabulated F-value at the 95% confidence level and for four degrees of freedom is 6.39).
Table 5
Results of recovery experiment through standard-addition method.
Method Tablet studied ETM in Tablet,
g/ml
Pure ETM added,
g/ml
Total found,
g/ml
Pure ETM recovered
Percent ± SDa
MTB Ethide 250
8.97 9 18.12 100.90 ± 0.84
8.97 18 26.88 99.76 ± 0.54
8.97 27 36.07 100.32 ± 0.77
PB Ethide 250
0.73 0.75 1.47 99.41 ± 1.23
0.73 1.50 2.26 101.44 ± 1.42
0.73 2.25 3.11 104.39 ± 1.65
a Mean value of three determinations.
the new methods and the reference method have similar
accuracy and precision.
4.6.  Accuracy  by  recovery  study
Accuracy of the proposed methods was further con-
firmed by recovery study following the standard-addition
procedure. Pre-analysed tablet powder was spiked with
pure ETM at three concentrations, and the total amount
was determined by the proposed methods. The percent
recovery values of pure drug added to tablet powder are
shown in Table 5. These results unambiguously demon-
strate that inactive ingredients such as talc, gelatin,
starch, magnesium stearate, sodium alginate, methylcel-
lulose, etc., do not interfere with the determination of the
active ingredient.
5.  Conclusion
The spectrophotometric methods described in this
study were found to be simple and did not involve
any critical experimental variables compared to most
reported methods. The methods were demonstrated to be
both accurate and precise, as well as robust and rugged.
Both systems have wide linear dynamic ranges of appli-
cability. Furthermore, the Prussian blue method had an
 value of 3.18 ×  104 l mol−1 cm−1, which is the most
sensitive one ever reported for ETM (Table 6). The refer-
ence method [4] requires a rigorous anhydrous medium
for accurate endpoint detection, as well as the gener-
ation of a large quantity of organic solvent as waste.
This creates a waste disposal problem; therefore, it is
not a green method. Additionally, the reference method
is applicable to a macro scale (300 mg drug per trial). In
contrast, the proposed methods seldom employ organic
solvents and are applicable over a micro scale (g/ml).
These advantages, coupled with the use of cheap and
readily available chemicals and simple instrumentation,
make the methods suitable for use in quantity control
laboratories in developing and underdeveloped countries
that can ill-afford the expensive techniques such as
HPLC.
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Table 6
Comparison of the proposed and the existing spectrophotometric methods.
Sl. No. Reagent/s Methodology Linear range
(g/ml)
LOD/LOQ
(g/ml)
Remark Ref. no.
1 Sodium
nitoprusside
Orange coloured product in basic
medium measured at 510 nm
20
2 Sodium
nitroprusside
Orange-red complex measured at
510 nm
5–32 Narrow range 21
3 DCNQ Orange coloured product in ethanol
measured at 440 nm
16
4 DCNQ Red coloured product formed in the
presence of ammonia in alcohol
medium measured at 530 nm
17
5 PAR-V(V) Ternary complex (1:1:1) extracted
into chloroform and measured at
560 nm
0.2–20 30 min contact time, involves
laborious liquid-liquid extraction
step
22
6 Iron(III) Purple-violet colour complex in acid
medium measured at 510 nm
0–36 Longer contact time 18
7 Iron(III)-PPD Thionine compound measured at
600 nm
Multiple step reaction involved 19
8 Osmic acid Light yellow coloured formed at pH4
measured at 375 nm
0.25–40 60 min contact time, pH
adjustment required
23
9 NBS-CB Unbleached dye colour measured in
acid medium at 540 nm
0.2–5.0 Critical acid conc.; concentration
of NBS &CB to be known
accurately
25
10 KMnO4 Blue coloured manganate in alkaline
medium measured at 610 nm (direct
method), absorbance at a fixed time
of 20 min measured (kinetic method)
1–10
1–10
Critical NaOH conc., reaction
rate precariously dependent on
experimental variables
26
11 Sodium azide-
iodine
Decrease in absorbance at the 5th min
measured at 348 nm (kinetic method)
10–100 0.7/– Reaction rate precariously
dependent on experimental
condition, narrow range, less
sensitive
27
12 (a) F–C reagent
(b) Fe(III)
ferricyanide
Mo–W blue measured at 760 nm
Prussian blue measured at 760 nm
1.0–40
0.2–4.0
0.09/0.27
0.01/0.04
No drastic experimental
conditions involved, no extraction
step, no critic pH, more sensitive,
wide linear dynamic ranges
Present
methods
DCNQ, dichloronaphthoquinone; PAR, pyridylazo resorcinol; PPD, p-phenylenediamine; NBS, N-bromosuccinimide; CB, Celestine blue.
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